r/investing Mar 15, 08:20 PM
Expanded distribution for REZENOPY™ naloxone nasal spray to 5,000+ U.S. healthcare institutions. addition to the REZENOPY expansion, Scienture is also advancing the launch of ARBLI, a liquid formulation of the widely used blood-pressure medication losartan. ARBLI is designed to address a specific need in the market for patients who have difficulty swallowing traditional tablets, which includes pediatric, geriatric, and certain medical populations. By offering an alternative delivery method for a commonly prescribed medication, the company is positioning itself in a niche but potentially valuable segment of the cardiovascular drug market.
The stock is currently trading around the mid-$0.50 range and has been attempting to hold above the 50-day moving average near $0.48, which many short-term traders view as an important level for confirming momentum. Holding above this area could indicate that buyers are beginning to step back into the stock after previous selling pressure.
Idk thou
submitted by /u/Salt_Scarcity_9027
[link] [comments]